Pronova strengthens its financial and IP positions

Pronova BioPharma ASA has raised its income and beaten off a challenge to two US patents for its lead product, Lovaza, paving the way for a further expansion in the US.  Lovaza is a prescription drug for heart disease which is derived from fish oil.